Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Brachio-cervical inflammatory myopathy: multilevel clinical, histopathological and multi-omic analyses of a syndrome variably associated with systemic sclerosis. | Acta Neuropathol | 2026 | 41934478 | PubTator, text mining | PubMed |
| Advances in Spatial Multi-Omics in Gastric Cancer. | Cells | 2026 | 41892326 | PubTator, text mining | PubMed |
| Monkeypox virus replication and host response in vaginal and ectocervical epithelial cells. | Virulence | 2026 | 41880196 | PubTator, text mining | PubMed |
| Decoding the role of CXC chemokines in pulmonary metastasis of colorectal cancer using integrative computational approaches. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41874611 | PubTator, text mining | PubMed |
| Traditional plant urologicals curb early uropathogenic E. coli infection and strengthen host innate defense. | Appl Microbiol Biotechnol | 2026 | 41872590 | PubTator, text mining | PubMed |
| Heterozygous NFKB1 variant causes inflammatory dysregulation shaped by broader genetic context in common variable immunodeficiency. | JCI Insight | 2026 | 41869721 | PubTator, text mining | PubMed |
| Single-cell dissection of pleural and systemic immunity uncovers pathogen-specific immune reprogramming in tuberculosis versus lung adenocarcinoma. | Inflamm Res | 2026 | 41865158 | PubTator, text mining | PubMed |
Isolation methods influence the biological properties of Wharton's Jelly-derived mesenchymal stem cells: A comparative study of yield, viability, proliferation, differentiation potential, and proteomic profiles. | PLoS One | 2026 | 41860834 | PubTator, text mining | PubMed |
| Short-term outcome and prognostic factors in acute fulminant myocarditis with acute kidney injury patients. | Front Med (Lausanne) | 2026 | 41852537 | PubTator, text mining | PubMed |
| Heterogeneity in inflammatory responses to endotoxin at the fetomaternal interface. | J Immunol | 2026 | 41847862 | PubTator, text mining | PubMed |
| Integrative multi-omics and machine learning reveals the spatial niche distribution and role of CYP27A1+TAMs in immunotherapy response in non-small cell lung cancer. | Front Immunol | 2026 | 41836417 | PubTator, text mining | PubMed |
| Systematic and precise interventions for KRAS-mutant cancers. | Exp Hematol Oncol | 2026 | 41827015 | PubTator, text mining | PubMed |
| Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances. | Mol Biomed | 2026 | 41826571 | PubTator, text mining | PubMed |
| Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis. | Sci Adv | 2026 | 41811963 | PubTator, text mining | PubMed |
| Identification of core genes mediating the association between obesity and hepatocellular carcinoma: A bioinformatics study based on mitochondrial metabolism and immune pathways. | PLoS One | 2026 | 41801960 | PubTator, text mining | PubMed |
| Identification and validation of biomarkers associated with lactic acid metabolism in diabetic nephropathy. | PeerJ | 2026 | 41800124 | PubTator, text mining | PubMed |
| A lytic bacteriophage vB_KpnP-6K2 inhibits ST11-KL64 Klebsiella pneumoniae induced cell death and inflammatory response. | Front Cell Infect Microbiol | 2026 | 41798745 | PubTator, text mining | PubMed |
| Lactoferrin blocks orthopoxvirus entry via heparan sulphate and regulates host antiviral pathways. | Emerg Microbes Infect | 2026 | 41790953 | PubTator, text mining | PubMed |
| Prognostic, chemotherapy and immunotherapy roles of GPR37/GPR37L1 in pan-cancer. | Medicine (Baltimore) | 2026 | 41790623 | PubTator, text mining | PubMed |
| ScRNA-seq reveals dynamic macrophage heterogeneity in chronic liver disease progression and prognostic biomarkers KLF2/SPP1 in HCC. | Front Immunol | 2026 | 41789089 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=2